Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 5Completed 4Not yet recruiting 3Recruiting 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 267Prostatic Neoplasms 144Neoplasms 139Lung Neoplasms 84Colorectal Neoplasms 61Motor Activity 55Uterine Cervical Neoplasms 44Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 35Head and Neck Neoplasms 34Colonic Neoplasms 34Ovarian Neoplasms 33Brain Neoplasms 32Carcinoma, Hepatocellular 27Neoplasm Metastasis 26Rectal Neoplasms 24Stomach Neoplasms 22Melanoma 19Hematologic Neoplasms 19Endometrial Neoplasms 19Liver Neoplasms 18Anxiety Disorders 18Kidney Neoplasms 16Glioma 16Squamous Cell Carcinoma of Head and Neck 15Papillomavirus Infections 15Fatigue 15Esophageal Neoplasms 15Obesity 14Multiple Myeloma 14

Interventions

Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Chemotherapy-Related Cognitive Impairment × Clear all
NCT04586530 2026-01-21

TAMS

University of Pittsburgh

Phase NA Active not recruiting
220 enrolled

Chemotherapy-Related Cognitive Impairment, Cognition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡